GURUFOCUS.COM » STOCK LIST » USA » NAS » Kodiak Sciences Inc (NAS:KOD) » Definitions » Profitability Rank
Switch to:

Kodiak Sciences Profitability Rank

: 1 (As of Mar. 2022)
View and export this data going back to 2018. Start your Free Trial

Kodiak Sciences has the Profitability Rank of 1. It has had trouble to make a profit.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Kodiak Sciences's Operating Margin % for the quarter that ended in Mar. 2022 was %. As of today, Kodiak Sciences's Piotroski F-Score is 3.


Competitive Comparison

For the Biotechnology subindustry, Kodiak Sciences's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Kodiak Sciences Profitability Rank Distribution

For the Biotechnology industry and Healthcare sector, Kodiak Sciences's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Kodiak Sciences's Profitability Rank falls into.



Kodiak Sciences Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Kodiak Sciences has the Profitability Rank of 1. It has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Kodiak Sciences's Operating Margin % for the quarter that ended in Mar. 2022 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2022 ) / Revenue (Q: Mar. 2022 )
=-95.767 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Kodiak Sciences has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


Kodiak Sciences Profitability Rank Related Terms

Thank you for viewing the detailed overview of Kodiak Sciences's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Kodiak Sciences Business Description

Kodiak Sciences logo
Traded in Other Exchanges
Address
1200 Page Mill Road, Palo Alto, CA, USA, 94304
Kodiak Sciences Inc is is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The most advanced product candidate of the group is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
Executives
Baker Julian director, 10 percent owner BAKER BROS. ADVISORS LP 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Baker Felix director, 10 percent owner BAKER BROS. ADVISORS LP 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Baker Bros. Advisors Lp director, 10 percent owner 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Baker Brothers Life Sciences Lp director, 10 percent owner 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
667, L.p. director, 10 percent owner 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Baker Bros. Advisors (gp) Llc director, 10 percent owner 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Bancroft Charles A director BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Yang Taiyin director 2631 HANOVER STREET PALO ALTO CA 94304
Levy Richard S director 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Profusek Robert director P.O. BOX 696000 SAN ANTONIO TX 78269-6000
Dahiyat Bassil I director C/O XENCOR, INC. 111 WEST LEMON AVENUE MONROVIA CA 91016
Ehrlich Jason officer: See Remarks 1200 PAGE MILL ROAD PALO ALTO CA 94304
Borgeson John A. officer: See Remarks 1200 PAGE MILL ROAD PALO ALTO CA 94304
Perlroth Victor director, 10 percent owner, officer: Chairman, President and CEO 1200 PAGE MILL ROAD PALO ALTO CA 94304
Liang Hong officer: See Remarks 2631 HANOVER STREET PALO ALTO CA 94304

Kodiak Sciences Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)